NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,555,250 | +17.0% | 713,113 | +28.6% | 0.41% | +20.2% |
| Q2 2023 | $26,978,223 | +9.7% | 554,423 | +25.1% | 0.34% | -1.2% |
| Q1 2023 | $24,603,466 | +524.7% | 443,146 | +351.9% | 0.34% | +484.7% |
| Q4 2022 | $3,938,749 | +66.3% | 98,052 | +81.4% | 0.06% | +63.9% |
| Q3 2022 | $2,369,000 | -93.3% | 54,052 | -85.6% | 0.04% | -90.0% |
| Q4 2021 | $35,130,000 | -65.3% | 376,166 | -58.6% | 0.36% | -70.1% |
| Q3 2021 | $101,135,000 | +12.7% | 907,528 | +14.8% | 1.20% | +0.8% |
| Q2 2021 | $89,761,000 | +14.6% | 790,635 | +2.5% | 1.19% | +2.9% |
| Q1 2021 | $78,306,000 | -4.6% | 771,185 | -6.5% | 1.16% | -12.9% |
| Q4 2020 | $82,048,000 | +42.5% | 824,437 | +3.4% | 1.33% | +12.2% |
| Q3 2020 | $57,590,000 | +48.0% | 797,199 | +2.2% | 1.18% | +24.9% |
| Q2 2020 | $38,909,000 | +72.3% | 780,371 | +3.2% | 0.95% | +25.3% |
| Q1 2020 | $22,586,000 | +53.5% | 756,400 | +73.2% | 0.76% | +93.1% |
| Q4 2019 | $14,710,000 | -34.8% | 436,624 | -36.5% | 0.39% | -46.7% |
| Q3 2019 | $22,548,000 | +24.0% | 687,441 | +4.3% | 0.73% | +28.8% |
| Q2 2019 | $18,180,000 | +36.4% | 659,177 | +18.4% | 0.57% | +39.0% |
| Q3 2018 | $13,331,000 | -37.1% | 556,856 | -50.6% | 0.41% | -42.7% |
| Q2 2018 | $21,194,000 | +116.4% | 1,126,168 | +6.6% | 0.72% | +106.9% |
| Q1 2018 | $9,794,000 | +5.1% | 1,056,512 | +1.9% | 0.35% | -2.3% |
| Q4 2017 | $9,320,000 | -36.6% | 1,036,706 | -9.2% | 0.35% | -38.2% |
| Q3 2017 | $14,710,000 | +26.3% | 1,141,178 | +6.4% | 0.57% | +33.9% |
| Q2 2017 | $11,649,000 | +48.8% | 1,072,610 | +21.5% | 0.43% | +59.7% |
| Q1 2017 | $7,830,000 | -49.7% | 882,753 | -33.7% | 0.27% | -51.4% |
| Q4 2016 | $15,581,000 | +20.6% | 1,330,587 | +14.4% | 0.55% | +26.1% |
| Q3 2016 | $12,917,000 | +0.2% | 1,162,645 | +8.8% | 0.44% | -5.0% |
| Q2 2016 | $12,890,000 | – | 1,068,397 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |